40 results
D
ORGS
Orgenesis Inc
14 Mar 24
$2.34 mm in equity / options / securities to be acquired, sold $2.34 mm, 46 investors
1:02pm
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health
8-K
EX-10.1
ORGS
Orgenesis Inc
7 Mar 24
Orgenesis Inc. Announces $2.3 Million Private Placement
12:11pm
the meaning of Section 3(3) of ERISA) subject to Title IV of ERISA with respect to which the Company may have any liability.
4.30 Environmental Laws … relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental
8-K
EX-10.1
ORGS
Orgenesis Inc
31 Jan 24
Entry into a Material Definitive Agreement
9:20am
, profits, license, lease, service, service use, withholding, payroll, employment, unemployment, estimated, excise, severance, environmental, stamp
8-K
EX-10.1
d4b8m gnw3zh
8 Nov 23
Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering
9:24am
D
k532dd05kqe1155n59b8
8 Sep 23
$1.00 mm in equity, sold $1.00 mm, 1 investor
4:05pm
8-K
EX-10.1
e96l9o3fy7q4whu6yma
1 Sep 23
Entry into a Material Definitive Agreement
6:04am
8-K
EX-10.1
xq8x9
7 Nov 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
xdhtdb sx
17 Aug 22
Entry into a Material Definitive Agreement
2:30pm
D
h2wl94v
14 Apr 22
$14.8M in equity / options, sold $14.8M, 2 investors
6:10am
8-K
EX-10.1
cltg3kgw2u a1l1x7t
5 Apr 22
Orgenesis Inc. Announces $14.8 Million Private Placement
5:10pm
8-K
EX-2.1
043q4j23q 8v5ypm
1 Oct 20
Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies
5:04pm
8-K
EX-10.1
4xdvq7k sf4vu4
13 Apr 20
Entry into a Material Definitive Agreement
4:43pm